CF Industries Short Position Reverses Course Before Q3 Earnings

Among nitrogen fertilizer producers heading into this earnings cycle, CF Industries now carries a lighter short position than it did two weeks ago, a notable reversal from the steady rebuilding documented through mid-October. Closest correlated peer NTR moved only modestly on the week, while LXU surged 16.5%, making CF's 2.2% weekly gain broadly in line with the peer group median.

Short interest dropped sharply after October 22, falling roughly 12% over the week to 5.6% of the free float. That reversal is significant: the previous note recorded short interest climbing to nearly 10 million shares by October 22 after a deliberate three-week rebuild. Since then, around 1.2 million shares of short exposure have been unwound. The weekly change in short interest is running 1.6 standard deviations below CF's typical weekly move, meaning the pace of covering is unusually fast relative to the stock's own history on this measure. ORTEX's short score has moved in tandem, easing from 45.4 on October 21 to 42.7 on October 29, consistent with the reduction in positioned bearish exposure.

The lending market remains uninformative as a signal. Availability is extraordinarily loose at roughly 1,281% of current short interest, with 118 million shares available to borrow against about 8.7 million currently lent. Borrowing costs have risen about 34% over the past week to 0.57%, but at that level they remain firmly low in absolute terms. There is no mechanical pressure on existing short positions. Options positioning is similarly relaxed: the put/call ratio of 0.75 sits just barely above its 20-day average of 0.75, essentially flat, with no meaningful skew toward either direction.

Analysts have been incrementally more constructive in recent weeks. UBS raised its target to $134 from $123 on October 27, maintaining a Neutral rating, and CIBC moved similarly to $133 from $125 on October 23. Both firms remain on the fence rather than outright bullish. The more aggressive call came from Bernstein in late September, which initiated at Outperform with a $162 target, while Keybanc initiated at the same time at Underweight with a $115 target. The mean consensus target is $128, just above the current price of $123.30. The debate splits cleanly: bulls point to stabilising nitrogen valuations, the Blue Point low-carbon ammonia project, and strong cash generation capacity; bears focus on potential Chinese urea export volumes, seasonal H2 demand softness, and the risk that rising LNG flows eventually compress global marginal nitrogen costs.

The Q3 print will test whether the abrupt short covering since October 22 was a confidence call ahead of the release, or simply profit-taking after a positioning overshoot.